A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03071757 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

139

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors Cancer

Interventions

DRUG: ABBV-368
DRUG: ABBV-181

Sponsor

AbbVie